CABA 10-Q: SEC filing
Cabaletta Bio, Inc.
Filed with the SEC on · accession 0001759138-26-000047
CABA filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Cabaletta Bio, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including equity awards, financing arrangements, and license agreements.
Key details
How CABA stock reacted
Close before
$1.42
Nov 4, 2026
First close after
-9.86%
$1.28
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CABA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CABA?
Click hereFrequently asked questions
What did CABA file with the SEC on Nov 5, 2026?
CABA filed a 10-Q (SEC filing). Cabaletta Bio, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including equity awards, financing arrangements, and license agreements.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CABA stock react to this filing?
CABA closed at $1.42 before the filing and $1.28 on Nov 5, 2026 (-9.86%).
Other CABA SEC filings
Get alerts when CABA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days